Diffusivity and distribution of vinblastine in three-dimensional tumour tissue: experimental and mathematical

Szabolcs Modok1, Philip Hyde, Howard R Mellor

  • 1Oxford Drug Resistance Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Headley Way Headington, Oxford OX3 9DU, UK.

European Journal of Cancer (Oxford, England : 1990)
|August 12, 2006
PubMed

Insights

Chemotherapy penetration in solid tumors is poorly understood. This study quantifies drug diffusion in tumor tissue, revealing vinblastine diffuses slowly, impacting treatment efficacy.

Area of Science:

  • Oncology
  • Pharmacology
  • Biophysics

Background:

  • Chemotherapeutic distribution within solid tumors significantly impacts treatment outcomes.
  • Understanding drug penetration is crucial for overcoming treatment failure in cancer therapy.
  • Interstitial pressure in poorly vascularized tumors limits convective drug transport.

Purpose of the Study:

  • To quantify the diffusive hindrance of solid tumor tissue on chemotherapeutic agents.
  • To investigate the impact of tumor architecture on drug availability.
  • To develop a mathematical model for predicting drug pharmacokinetic behavior in tumors.

Main Methods:

  • Utilized multicell layer tumor models with DLD1 colon cancer cells.
  • Measured diffusion fluxes for [3H]-vinblastine and [14C]-sucrose.
  • Employed mathematical modeling to determine diffusion coefficients and predict drug exposure.

Main Results:

  • Developed a mathematical model to accurately quantify drug diffusion in solid tumor tissue.
  • Vinblastine diffusion was found to be three times slower than sucrose diffusion.
  • Predicted higher drug exposure for cancer cells located near tumor vasculature.

Conclusions:

  • Slow diffusion of vinblastine may delay penetration into avascular tumor regions.
  • The developed mathematical model accurately quantifies drug diffusivity within solid tissue.
  • This model can be adapted to include factors contributing to pharmacokinetic drug resistance.

Related Concept Videos

Volume of Distribution01:20

Volume of Distribution

The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Three-Compartment Open Model01:06

Three-Compartment Open Model

The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...